Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Apr 1;6(5):244-248.
doi: 10.1016/j.hrcr.2020.03.016. eCollection 2020 May.

An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine

Affiliations
Case Reports

An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine

Raman L Mitra et al. HeartRhythm Case Rep. .
No abstract available

Keywords: Acquired LQTS; Azithromycin; COVID-19; Chloroquine; Drug toxicity; Flow chart; Hydroxychloroquine; Long QT; Pandemic; Proarrhythmia; Torsades de pointes; Ventricular fibrillation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chest computed tomography of patient on March 16, 2020, showing extensive right lung infiltrates.
Figure 2
Figure 2
A: Electrocardiogram (ECG) showing prolonged QTc of 620 ms using Bazett’s formula after 1 dose of hydroxychloroquine in a patient on azithromycin. B: ECG 30 minutes after administration of 100 mg intravenous (IV) lidocaine with reduction of QTc to 550 ms.
Figure 3
Figure 3
Flow chart to manage effects on QTc with chloroquine, hydroxychloroquine with azithromycin. bpm = beats per minute; Dob = dobutamine; ECG = electrocardiogram; Epi = epinephrine; IV = intravenous; K = serum potassium; LQTS = long QT syndrome; Mg = serum magnesium; NE = norepinephrine; TdP = torsades de pointes.

References

    1. Colson P., Rolain J.M., Lagier J.C., Brouqui P., Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 [published online ahead of print March 4, 2020]. Int J Antimicrob Agents. https://doi.org/10.1016/j.ijantimicag.2020.105932 - DOI - PMC - PubMed
    1. Gao J., Tian Z., Breakthrough Yang X. Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14:72–73. - PubMed
    1. Gautret P., Lagier J.C., Parola P. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial [published online ahead of print March 20, 2020]. Int J Antimicrob Agents. https://doi.org/10.1016/j.ijantimicag.2020.105949 - DOI - PMC - PubMed
    1. Dunne M.W., Singh N., Shukla M. A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. J Infect Dis. 2005;191:1582–1588. - PubMed
    1. Chico R.W., Chandramohan D. Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy. Expert Opin Drug Metab Toxicol. 2011;7:1153–1167. - PMC - PubMed

Publication types

LinkOut - more resources